🔎 Trials Near Me

Utama › Neuroblastoma › Wilayah Columbia › Washington

Kajian klinikal Neuroblastoma di Washington, DC

11 kajian untuk Neuroblastoma sedang mencari peserta di lokasi dalam dan sekitar Washington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

Mengambil pesertaFasa 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Umur 18 hingga 120 · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06041516

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
4 Weeks · Semua jantina · Dikemas kini 2 Okt 2026 · NCT01109394

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Mengambil pesertaFasa 3
  • Children's National Medical Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi jauh
Sehingga umur 30 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06172296

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

Mengambil pesertaFasa 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Umur 3 hingga 35 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06995872

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Mengambil pesertaKajian pemerhatian
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Umur 4 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT01005654

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Mengambil pesertaFasa 3
  • Children's National Medical Center, Washington D.C.
365 Days – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Mengambil pesertaFasa 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04851119

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

Mengambil pesertaFasa 1
  • Children's National Hospital, Washington D.C.
  • Childrens National Hospital, Washington D.C.
Umur 1 hingga 23 · Semua jantina · Dikemas kini 13 Ogo 2026 · NCT07172958

SPEARHEAD-3 Pediatric Study

Mengambil pesertaFasa 1/2
  • National Institutes of Health, Bethesda · 7 mi jauh
Umur 2 hingga 21 · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05642455

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Mengambil pesertaFasa 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Semua jantina · Dikemas kini 19 Mei 2026 · NCT04901702

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Mengambil pesertaFasa 2
  • Children's National Medical Center, Washington D.C.
18 Months – 40 Years · Semua jantina · Dikemas kini 12 Ogo 2025 · NCT05135975

Kajian Neuroblastoma di bandar lain

Kajian lain di Washington

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.